234 related articles for article (PubMed ID: 30076181)
1. 2-Bromopalmitate targets retinoic acid receptor alpha and overcomes all-trans retinoic acid resistance of acute promyelocytic leukemia.
Lu Y; Yan JS; Xia L; Qin K; Yin QQ; Xu HT; Gao MQ; Qu XN; Sun YT; Chen GQ
Haematologica; 2019 Jan; 104(1):102-112. PubMed ID: 30076181
[TBL] [Abstract][Full Text] [Related]
2. Antitumor synergy with SY-1425, a selective RARα agonist, and hypomethylating agents in retinoic acid receptor pathway activated models of acute myeloid leukemia.
McKeown MR; Johannessen L; Lee E; Fiore C; di Tomaso E
Haematologica; 2019 Apr; 104(4):e138-e142. PubMed ID: 30337363
[No Abstract] [Full Text] [Related]
3. CUDC-101 overcomes arsenic trioxide resistance via caspase-dependent promyelocytic leukemia-retinoic acid receptor alpha degradation in acute promyelocytic leukemia.
Zhang T; Ma D; Wei D; Lu T; Yu K; Zhang Z; Wang W; Fang Q; Wang J
Anticancer Drugs; 2020 Feb; 31(2):158-168. PubMed ID: 31584454
[TBL] [Abstract][Full Text] [Related]
4. NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK.
Xiao C; Zhong L; Shan Z; Xu T; Gan L; Song H; Yang R; Li L; Liu B
Int J Med Sci; 2016; 13(8):611-9. PubMed ID: 27499693
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient.
Koken MH; Daniel MT; Gianni M; Zelent A; Licht J; Buzyn A; Minard P; Degos L; Varet B; de Thé H
Oncogene; 1999 Jan; 18(4):1113-8. PubMed ID: 10023688
[TBL] [Abstract][Full Text] [Related]
6. The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.
Jing Y
Leuk Lymphoma; 2004 Apr; 45(4):639-48. PubMed ID: 15160934
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN.
Yao S; Zhong L; Chen M; Zhao Y; Li L; Liu L; Xu T; Xiao C; Gan L; Shan Z; Liu B
Int J Oncol; 2017 Sep; 51(3):899-906. PubMed ID: 28766684
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia.
Lallemand-Breitenbach V; Guillemin MC; Janin A; Daniel MT; Degos L; Kogan SC; Bishop JM; de Thé H
J Exp Med; 1999 Apr; 189(7):1043-52. PubMed ID: 10190895
[TBL] [Abstract][Full Text] [Related]
9. Acute promyelocytic leukemia with a PLZF-RARalpha fusion protein.
Jansen JH; Löwenberg B
Semin Hematol; 2001 Jan; 38(1):37-41. PubMed ID: 11172538
[TBL] [Abstract][Full Text] [Related]
10. LG-362B targets PML-RARα and blocks ATRA resistance of acute promyelocytic leukemia.
Wang X; Lin Q; Lv F; Liu N; Xu Y; Liu M; Chen Y; Yi Z
Leukemia; 2016 Jul; 30(7):1465-74. PubMed ID: 27012866
[TBL] [Abstract][Full Text] [Related]
11. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells.
Duprez E; Lillehaug JR; Gaub MP; Lanotte M
Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.
Liu X; Chen J; Yu S; Yan L; Guo H; Dai J; Zhang W; Zhu J
Cell Death Dis; 2017 May; 8(5):e2782. PubMed ID: 28492552
[TBL] [Abstract][Full Text] [Related]
13. ZYH005, a novel DNA intercalator, overcomes all-trans retinoic acid resistance in acute promyelocytic leukemia.
Tong Q; You H; Chen X; Wang K; Sun W; Pei Y; Zhao X; Yuan M; Zhu H; Luo Z; Zhang Y
Nucleic Acids Res; 2018 Apr; 46(7):3284-3297. PubMed ID: 29554366
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ
Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743
[TBL] [Abstract][Full Text] [Related]
15. Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression.
Xu K; Guidez F; Glasow A; Chung D; Petrie K; Stegmaier K; Wang KK; Zhang J; Jing Y; Zelent A; Waxman S
Cancer Res; 2005 Sep; 65(17):7856-65. PubMed ID: 16140955
[TBL] [Abstract][Full Text] [Related]
16. Mutant AF-2 domain of PML-RARalpha in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARalpha and its down-regulation in acute promyelocytic leukemia.
Kitamura K; Kiyoi H; Yoshida H; Saito H; Ohno R; Naoe T
Leukemia; 1997 Nov; 11(11):1950-6. PubMed ID: 9369431
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis inducing and differentiation enhancement effect of oridonin on the all-trans-retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells.
Gao F; Tang Q; Yang P; Fang Y; Li W; Wu Y
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e114-22. PubMed ID: 19302235
[TBL] [Abstract][Full Text] [Related]
18. The combination of UCN-01 and ATRA triggers differentiation in ATRA resistant acute promyelocytic leukemia cell lines via RAF-1 independent activation of MEK/ERK.
Liang C; Ding M; Weng XQ; Sheng Y; Wu J; Cai X
Food Chem Toxicol; 2019 Apr; 126():303-312. PubMed ID: 30840849
[TBL] [Abstract][Full Text] [Related]
19. [All-trans retinoic acid promotes differentiation of human leukemia cells by degrading NLS-RARα].
Li J; Liu B; Ye J; Xiong L; Yu L; Zhong P; Yuan Z; Liu D; Yao J; Liu J; Zhong L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Dec; 35(12):1082-1087. PubMed ID: 31894006
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα-Driven Leukemia.
Coltella N; Valsecchi R; Ponente M; Ponzoni M; Bernardi R
Clin Cancer Res; 2015 Aug; 21(16):3685-94. PubMed ID: 25931453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]